Bio-BDMC™30 is a patented curcumin extract featuring the highest concentration of BDMC (bisdemethoxycurcumin) available globally. In standard curcumin extracts, BDMC is present in very low concentrations, typically between 0.5% to 1.5%. By increasing it to 30% (BDM30), this extract offers a significant advancement in inflammatory therapy at both the genetic and subcellular levels.

BDM30 effectively targets and neutralizes a key nuclear protein that halts the production of inflammatory proteins, providing a more precise curcumin therapy. Unlike regular curcumin, which only inhibits NF-kB, BDMC inhibits both NF-kB and MSK1, addressing inflammation from two distinct targets.